IPP Bureau
Vijaya Medical and Educational Trust, Vadapalani adopts AI-based monitoring technology
By IPP Bureau - March 29, 2023
Vijaya Hospital, Chennai adopted Dozee’s AI-based contactless continuous remotemonitoring and early warning system to enhance patient safety
Sanofi receives marketing approval for its diabetes drug Soliqua in India
By IPP Bureau - March 29, 2023
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
Thalassemics India celebrates 35 years of service in Thalassemia
By IPP Bureau - March 29, 2023
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
Agilent presents 2023 Darlene Solomon Award to Kathryn Wolhuter
By IPP Bureau - March 28, 2023
The award recognizes and supports promising female scientists working in mass spectrometry
Thermo Fisher Scientific opens cell therapy facility at University of California
By IPP Bureau - March 28, 2023
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
Govt. reviews public health preparedness for management of COVID-19
By IPP Bureau - March 28, 2023
States advised to undertake mock drills to ensure operational readiness of Hospital Infrastructure including Oxygen Cylinders, PSA plants, ventilators and human resources
Integrated strategy needed to achieve 'TB Mukt Bharat'
By IPP Bureau - March 28, 2023
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
Lupin receives tentative approval from USFDA for Valbenazine capsules
By IPP Bureau - March 28, 2023
Valbenazine Capsules (RLD Ingrezza) had estimated annual sales of USD 1,235 million in the U.S. (IQVIA MAT December 2022).
Briefs: Morepen Laboratories and Zydus Lifesciences
By IPP Bureau - March 27, 2023
The company is addressing these observations
Lupin announces completion of pharmacovigilance inspection by USFDA
By IPP Bureau - March 27, 2023
The inspection included a comprehensive scrutiny of practices and procedures for reporting of adverse events of Lupin’s marketed products worldwide
Lupin announces successful completion of UK MHRA inspection of Pithampur facilities
By IPP Bureau - March 27, 2023
With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company
India ready to be voice of the global south in collaborative fight against TB: Dr. Mandaviya
By IPP Bureau - March 27, 2023
India has a pivotal role in eliminating TB
Ayush Ministry signs MoU with Department of ex-servicemen welfare
By IPP Bureau - March 27, 2023
Ayurveda OPD will be established in 10 ECHS Polyclinic/Dispensaries in various regions of India to cover all ECHS members on a voluntary basis
IIT Kanpur and University at Buffalo to enrich research in Biomedicine & Bioengineering
By IPP Bureau - March 25, 2023
The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering
Pfizer acquisition of ADC trailblazer Seagen a worthy investment: GlobalData
By IPP Bureau - March 25, 2023
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
